Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Supportive treatments, such as erythropoiesis-stimulating agents (ESAs), are commonly used in patients with low-risk MDS. This study aimed to retrospectively assess the impact of bone marrow Mothers against decapentaplegic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bedrettin Orhan, Hülya Öztürk Nazlıoğlu, Oğuzhan Dik, Büşra Gürbüz, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar Pınar, Cumali Yalçın Yalçın, Sinem Çubukçu, Tuba Güllü Koca, Fazıl Çağrı Hunutlu, Şeyma Yavuz, Rıdvan Ali, Fahir Özkalemkaş
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-03-01
coleção:	Biomolecules & Biomedicine
Assuntos:	Myelodysplastic syndrome MDS Mothers against decapentaplegic homolog 7 SMAD-7 Transforming Growth Factor Beta 1 TGF-β1
Acesso em linha:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/11564
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!